Historical record - last NADAC effective date: 7/1/2024
Product Information
TIROSINT-SOL 112 MCG/ML SOLN is a brand product labeled by IBSA Pharma Inc., priced at $4.4971 per ML under NDC 71858013505. Its NADAC has been published 16 times since Jun 19, 2024.
FDA first approved this application on Dec 15, 2016.
The High Outlier badge above means this manufacturer's average price in the Levothyroxine Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
112 ug/mL
Manufacturer
IBSA Pharma Inc.NDC
71858013505
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
7/1/2024
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA206977FDA Approved
12/15/2016
On Market Since
3/1/2019
Pharmacological Classes
Price Statistics
The NADAC for TIROSINT-SOL 112 MCG/ML SOLN has been published 16 times since Jun 19, 2024, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4971 per ML |
|---|---|
| All-time high | $4.4971 (Oct 2, 2024) |
| All-time low | $4.3409 (Jun 19, 2024) |
| Median price | $4.4971 |
| Average price | $4.4873 |
| Largest weekly change | +3.6% (Jun 26, 2024) |
| Weeks tracked | 16 |
| Tracking since | Jun 19, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+3.6%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levothyroxine Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIROSINT-SOL 112 MCG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for TIROSINT-SOL 112 MCG/ML SOLN, manufactured by IBSA Pharma Inc., is $4.4971 per ML (NDC 71858013505), effective Oct 2, 2024.
How has the price of TIROSINT-SOL 112 MCG/ML SOLN changed over time?
Over the history we have for it, the NADAC for TIROSINT-SOL 112 MCG/ML SOLN has risen 3.6%. It has been tracked across 16 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for TIROSINT-SOL 112 MCG/ML SOLN?
Since Jun 19, 2024, the NADAC for TIROSINT-SOL 112 MCG/ML SOLN has ranged from a low of $4.3409 (Jun 19, 2024) to a high of $4.4971 (Oct 2, 2024), with a median of $4.4971 per ML.
Are there cheaper alternatives to TIROSINT-SOL 112 MCG/ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of TIROSINT-SOL 112 MCG/ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIROSINT-SOL 112 MCG/ML SOLN?
TIROSINT-SOL 112 MCG/ML SOLN (NDC 71858013505) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.